NightHawk Biosciences announced its Scorpius BioManufacturing subsidiary has been awarded a project to support a preclinical program for a U.S. based biotech company. The initial project value exceeds one million dollars, with the potential to exceed several million dollars over the next two years.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.109 USD | -9.47% | +4.61% | -75.24% |
May. 20 | Scorpius Holdings, Inc. Announces Major Expansion in San Antonio with New Storage and Testing Facility | CI |
May. 14 | Top Midday Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-75.24% | 11.59M | |
+14.26% | 79.23B | |
+10.30% | 8.66B | |
+57.26% | 4.89B | |
-16.24% | 4.72B | |
+1.45% | 3.81B | |
+20.93% | 2.42B | |
-26.19% | 2.22B | |
+16.04% | 2.08B | |
-37.26% | 1.96B |
- Stock Market
- Equities
- SCPX Stock
- News Scorpius Holdings, Inc.
- Nighthawk?S Scorpius Biomanufacturing Subsidiary Commences Work on Preclinical Program for New Client